158 related articles for article (PubMed ID: 18588960)
1. Is the acceptable daily intake as presently used an axiom or a dogma?
Galli CL; Marinovich M; Lotti M
Toxicol Lett; 2008 Aug; 180(2):93-9. PubMed ID: 18588960
[TBL] [Abstract][Full Text] [Related]
2. Background to the ADI/TDI/PTWI.
Herrman JL; Younes M
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
[TBL] [Abstract][Full Text] [Related]
3. Precision of estimates of an ADI (or TDI or PTWI).
Speijers GJ
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
[TBL] [Abstract][Full Text] [Related]
4. Incidence and severity in relation to magnitude of intake above the ADI or TDI: use of critical effect data.
Renwick AG
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S79-86. PubMed ID: 10597618
[TBL] [Abstract][Full Text] [Related]
5. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
Hasegawa R; Koizumi M; Hirose A
Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the risk of exceeding the acceptable or tolerable daily intake.
Renwick AG; Walker R
Regul Toxicol Pharmacol; 1993 Dec; 18(3):463-80. PubMed ID: 8128007
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity modeling for risk assessment.
Kodell RL; Chen JJ; Gaylor DW
Regul Toxicol Pharmacol; 1995 Aug; 22(1):24-9. PubMed ID: 7494899
[TBL] [Abstract][Full Text] [Related]
8. The use of an additional safety or uncertainty factor for nature of toxicity in the estimation of acceptable daily intake and tolerable daily intake values.
Renwick AG
Regul Toxicol Pharmacol; 1995 Dec; 22(3):250-61. PubMed ID: 8837849
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicology dose/response assessment for several cholinesterase inhibitors: use of uncertainty factors.
Raffaele KC; Rees C
Neurotoxicology; 1990; 11(2):237-56. PubMed ID: 2234543
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment of thujone in foods and medicines containing sage and wormwood--evidence for a need of regulatory changes?
Lachenmeier DW; Uebelacker M
Regul Toxicol Pharmacol; 2010 Dec; 58(3):437-43. PubMed ID: 20727933
[TBL] [Abstract][Full Text] [Related]
11. Does EU legislation allow the use of the Benchmark Dose (BMD) approach for risk assessment?
Brandon EF; Bulder AS; van Engelen JG; Mahieu CM; Mennes WC; Pronk ME; Rietveld AG; van de Ven BM; Ten Voorde SE; Wolterink G; Slob W; Zeilmaker MJ; Bessems JG
Regul Toxicol Pharmacol; 2013 Nov; 67(2):182-8. PubMed ID: 23871753
[TBL] [Abstract][Full Text] [Related]
12. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
Bokkers BG; Slob W
Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
[TBL] [Abstract][Full Text] [Related]
13. Highest Observed Intake: definition, regulatory uses and provisional values.
Hathcock J; Kriengsinyos W
Regul Toxicol Pharmacol; 2011 Oct; 61(1):115-8. PubMed ID: 21802469
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment of micronutrients.
Renwick AG; Walker R
Toxicol Lett; 2008 Aug; 180(2):123-30. PubMed ID: 18586418
[TBL] [Abstract][Full Text] [Related]
15. The current state of knowledge on the use of the benchmark dose concept in risk assessment.
Sand S; Victorin K; Filipsson AF
J Appl Toxicol; 2008 May; 28(4):405-21. PubMed ID: 17879232
[TBL] [Abstract][Full Text] [Related]
16. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
17. Towards a harmonized approach for risk assessment of genotoxic carcinogens in the European Union.
Crebelli R
Ann Ist Super Sanita; 2006; 42(2):127-31. PubMed ID: 17033132
[TBL] [Abstract][Full Text] [Related]
18. The use of myocardial and testicular end points as a basis for estimating a proposed tolerable daily intake for sodium monofluoroacetate (1080).
Foronda NM; Fowles J; Smith N; Taylor M; Temple W; Darlington C
Regul Toxicol Pharmacol; 2007 Feb; 47(1):29-36. PubMed ID: 17030370
[TBL] [Abstract][Full Text] [Related]
19. Environmental risk assessment of zinc in European freshwaters: a critical appraisal.
Van Sprang PA; Verdonck FA; Van Assche F; Regoli L; De Schamphelaere KA
Sci Total Environ; 2009 Oct; 407(20):5373-91. PubMed ID: 19631966
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
Shao A; Hathcock JN
Regul Toxicol Pharmacol; 2008 Apr; 50(3):376-99. PubMed ID: 18325648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
